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Neuronal activity within and across the cortex and basal ganglia is pathologically synchronized, particularly at  20Hz in
patients with Parkinson’s disease. Deﬁning how activities in spatially distributed brain regions overtly synchronize in narrow
frequency bands is critical for understanding disease processes like Parkinson’s disease. To address this, we studied cortical
responses to electrical stimulation of the subthalamic nucleus (STN) at various frequencies between 5 and 30Hz in two cohorts
of eight patients with Parkinson’s disease from two different surgical centres. We found that evoked activity consisted of a
series of diminishing waves with a peak latency of 21ms for the ﬁrst wave in the series. The cortical evoked potentials (cEPs)
averaged in each group were well ﬁtted by a damped oscillator function (r50.9, P50.00001). Fits suggested that the natural
frequency of the subthalamo-cortical circuit was around 20Hz. When the system was forced at this frequency by stimulation of
the STN at 20Hz, the undamped amplitude of the modelled cortical response increased relative to that with 5Hz stimulation in
both groups (P40.005), consistent with resonance. Restoration of dopaminergic input by treatment with levodopa increased
the damping of oscillatory activity (as measured by the modelled damping factor) in both patient groups (P40.001). The
increased damping would tend to limit resonance, as conﬁrmed in simulations. Our results show that the basal ganglia–cortical
network involving the STN has a tendency to resonate at  20Hz in Parkinsonian patients. This resonance phenomenon may
underlie the propagation and ampliﬁcation of activities synchronized around this frequency. Crucially, dopamine acts to increase
damping and thereby limit resonance in this basal ganglia–cortical network.
Keywords: synchronization; basal ganglia; resonance; Parkinson’s disease; deep brain stimulation
Abbreviations: cEP=cortical evoked potential; DBS=deep brain stimulation; MRI=magnetic resonance imaging;
STN=subthalamic nucleus; UPDRS=Uniﬁed Parkinson’s Disease Rating Scale
Introduction
Electrophysiological recordings in patients with Parkinson’s disease
and animal models of this disorder demonstrate an exaggerated
and oscillatory synchronization of neuronal activity in the basal
ganglia at frequencies below about 30Hz (Rivlin-Etzion et al.,
2006; Uhlhaas and Singer, 2006; Hammond et al., 2007). Such
prominent synchronization is not seen in healthy animals and is
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and by dopamine agonists, in tandem with an improvement in
symptomatology. This has lead to the suggestion that pathological
synchrony at low frequency is mechanistically linked to phenotypic
features of Parkinson’s disease, such as tremor, slowness of
movement and stiffness, although this remains to be established
(Rivlin-Etzion et al., 2006; Uhlhaas and Singer, 2006; Hammond
et al., 2007).
In patients with Parkinson’s disease, in whom most data
comes from surgical implantation of the subthalamic nucleus
(STN) or globus pallidus, pathological synchrony tends to occur
at  20Hz (Brown et al., 2001; Cassidy et al., 2002; Williams
et al., 2002; Priori et al., 2004; Alegre et al., 2005; Foffani
et al., 2005; Kuhn et al., 2005; Alonso-Frech et al., 2006;
Devos et al., 2006; Fogelson et al., 2006; Weinberger et al.,
2006; Lalo et al., 2008; Steigerwald et al., 2008; Bronte-Stewart
et al., 2009). More recently, it has become clear that excessive
synchrony is a feature of the entire basal ganglia–cortical network
in Parkinson’s disease, with populations of neurons not only
synchronizing their activity locally, but also across levels. Thus,
there is coherent rhythmic activity both between nuclei in
the basal ganglia (Brown et al., 2001; Cassidy et al., 2002;
Goldberg et al., 2004; Foffani et al., 2005), and between these
and cortical areas (Marsden et al., 2001; Williams et al., 2002;
Sharott et al., 2005; Fogelson et al., 2006; Lalo et al., 2008).
In particular, in patients with Parkinson’s disease, there is strong
coherence between activity in STN and the cortex centred around
20Hz (Marsden et al., 2001; Williams et al., 2002; Fogelson et al.,
2006; Lalo et al., 2008). Such synchronization at  20Hz has
been associated with slowness of movement in both correlative
(Brown and Williams, 2005; Kuhn et al., 2006b, 2008, 2009;
Weinberger et al., 2006; Ray et al., 2008) and interventional
(Fogelson et al., 2005a; Chen et al., 2007; Eusebio et al., 2008)
studies. Even though a causal rather than epiphenomenal link
between this pathological synchronization and motor impairment
is by no means proven, synchronization at  20Hz therefore
appears worthy of further investigation as it may provide insight
into the pathophysiology of parkinsonism.
Here, we explore the mechanism of the strong coupling
of oscillations at  20Hz across basal ganglia–thalamo–cortical
circuits, and propose and test the hypothesis that dopaminergic
hypoactivity in Parkinson’s disease exposes a network resonance
at  20Hz that favours the propagation of activity at this patho-
logical frequency around basal ganglia–cortical loops in patients
with Parkinson’s disease. To this end, we studied the cortical
response to STN stimulation in Parkinson’s disease patients receiv-
ing therapeutic high frequency deep brain stimulation (DBS)
through electrodes implanted in the STN.
Materials and Methods
Patients and surgery
Most recordings were performed in eight patients (eight males, mean
age 58.0 years 3.0; mean disease duration 14.1 years 1.6) in
London. Patients participated with written informed consent and the
permission of the Joint Ethics Committee of the National Hospital for
Neurology and Neurosurgery and the Institute of Neurology. However,
we also repeated the main experiment in an independent population
of eight similar Parkinson’s disease patients (seven males, mean age
62.1 years 2.0; mean disease duration 12.8 years 1.5) recorded in
Marseille. These patients participated with written informed consent
and the permission of the local Ethics Committee (CPP Marseille 2).
The clinical details of all patients are summarized in Supplementary
Table 1. Implantation of bilateral STN DBS electrodes was performed
in all subjects for treatment of Parkinson’s disease at least 6 months
prior to study (mean 29.9 months 3.6). The implanted pulse
generator used was a Kinetra (Medtronic Neurological Division,
Minneapolis, USA). The DBS electrode used was model 3389
(Medtronic Neurological Division, Minneapolis, USA) with four platinum-
iridium cylindrical surfaces (1.27mm diameter and 1.5mm length)
and a centre-to-centre separation of 2mm. Contact 0 was the most
caudal and Contact 3 was the most rostral. The intended coordinates
at the tip of Contact 0 were 10–12mm from the midline, 0–2mm
behind the midcommissural point and 3–5mm below the anterior
commissural-posterior commissural line. For the patients operated in
London, adjustments to the intended coordinates were made in accor-
dance with the direct visualization of STN in individual stereotactic
MRI (Hariz et al., 2003) and implantation performed under local
anaesthesia. Correct placement of the DBS electrodes in the region
of the STN was further supported by: (i) effective intra-operative
macro-stimulation; (ii) immediate postoperative stereotactic
T2-weighted MRI compatible with the placement of at least one elec-
trode contact in the STN region; (iii) signiﬁcant improvement in UPDRS
motor score during chronic DBS off medication (14.9 2.5) compared
with UPDRS off medication with stimulator switched off (44.8 4.5;
P50.0001, paired t-test). The patients operated in Marseille were
implanted under light general anaesthesia as previously described
(Witjas et al., 2004). Intended coordinates were adjusted according
to the direct visualization of STN in stereotactic MRI performed
under general anaesthesia. Correct placement of the DBS electrodes
in the region of the STN was further supported by: (i) intra-operative
micro-recordings (ﬁve electrodes on each side); (ii) intra-operative
macro-stimulation for the detection of capsular spread; (iii) intra-
operative stereotactic telemetric radioscopy and immediate post-
operative CT-scan providing ﬁnal coordinates of each contact; (iv)
signiﬁcant improvement in UPDRS motor score during chronic
DBS off medication (11.5 3.0) compared with UPDRS off medica-
tion with stimulator switched off (32.8 3.2; P50.0001, paired
t-test).
Protocol
Our aim was to artiﬁcially synchronize activity in the STN area at
different frequencies and to follow changes in its propagation charac-
teristics, as indicated by the amplitude of the cortical evoked potentials
(cEPs). Previous studies have shown that DBS applied in the vicinity
of the STN reliably induces a cEP with a peak latency of 20–25ms
predominantly over the sensorimotor cortex of Parkinson’s disease
patients and likely to reﬂect orthodromic activation of basal ganglia
projections to the cortex (Baker et al., 2002; MacKinnon et al., 2005).
Earlier potentials (510ms) occur, but may be more inconsistently
observed, at least in part because of their obscuration by stimulation
artefact. For example, MacKinnon et al. (2005) found these after
stimulation of only 6 out of 14 electrodes. These early potentials
may represent the effects of anti-dromic activation of the hyperdirect
pathway (Ashby et al., 2001; Baker et al., 2002; MacKinnon et al.,
2005). As we wanted to speciﬁcally test the transfer function of
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possible, we choose to stimulate those DBS contacts affording the
best clinical response, even though the highest amplitude cEPs may
often be obtained with DBS applied through more dorsal contacts
(MacKinnon et al., 2005).
All 16 patients were assessed after overnight withdrawal of anti-
parkinsonian medication. Fifteen of the patients (those in whom
a signiﬁcant cEP was found; see below) were also recorded during
another experimental session after administration, in a dispersible
form, of their morning levodopa-equivalent dose of medication or
200mg of levodopa, whichever was the higher. Experimental sessions
on and off medication were performed on separate days due to time
constraints. In London, the two experimental sessions were separated
by a mean of 47 7 days and the ON-drug session always followed
the OFF-drug session. In Marseille, the two experimental sessions took
place on two consecutive days and the OFF-drug session followed the
ON-drug in two patients. In the OFF-drug state, the stimulator was
switched off for at least 20min and basal OFF-drug OFF-stim UPDRS
III scoring was performed. About 75% of the UPDRS III score decrease
occurs within this time frame following discontinuation of DBS
(Temperli et al., 2003). All patients had maximal clinical effect using
monopolar DBS (the implanted pulse generator being the anode).
However, in this conﬁguration, the stimulus artefact prevents any
analysis of the evoked potentials (MacKinnon et al., 2005).
Accordingly, the stimulator was turned back on using a bipolar
conﬁguration and the voltage increased to 130% of the monopolar
voltage by way of compensation (MacKinnon et al., 2005). There was
no evidence of capsular spread during DBS, as determined by clinical
examination. The negative contact was the one used by the patient in
a monopolar conﬁguration. The positive contact was chosen next to
the negative one. When the active contact was between two other
contacts, the positive contact producing the best clinical effect was
utilized. The pairs of contacts chosen for all patients are summarized
in Supplementary Table 1. In addition, postoperative MRI or CT-scan
was consistent with placement of at least one of these two contacts in
the STN region. The clinical effect was assessed using the UPDRS III
score after 20min of DBS using the patients’ usual therapeutic
stimulation frequency and pulse width. All patients improved their
UPDRS III score by at least 30% (mean 50.6% 2.4 in London
and 63.6% 6.6 in Marseille; P40.0001 for both, paired t-tests),
consistent with stimulation of the local STN area.
The Kinetra stimulator stimulates alternately both sides, producing
an artefact at twice the frequency actually used. Therefore, to avoid
this and any interaction of evoked potentials elicited at different times
from the two hemispheres, only the side with the best clinical beneﬁt
of DBS (assessed by the UPDRS III score) was stimulated (nine right
sides). The same side was stimulated in the OFF- and ON-drug
conditions using the same DBS parameters. In both conditions, the
stimulator was turned off for the other side. Efﬁcacy of the levodopa
administration in the ON-drug state was assessed using the UPDRS III
score about 30min after ingestion of levodopa with the stimulator
ON with the usual therapeutic parameters in order to diminish the
discomfort of the patients (ON-DBS ON-drug state). All patients felt
at ‘‘best ON’’ and improved their UPDRS III score by at least 25%
compared with the ON-DBS OFF-drug state (mean 52.3% 5.9 in
London and 60.4% 8.4 in Marseille; P40.005 for both, paired
t-tests) before the start of the recording in the ON-drug state.
Moreover, eleven of them experienced peak-dose dyskinesias through-
out the recording in the ON-drug state. The four patients who did not
have dyskinesias were not usually prone to this kind of abnormal
movement in the ON-drug state. The duration of the experiment
( 90min) was consistent with the duration of efﬁcacy of the
medication. On three occasions, however, an additional dose of
200mg levodopa was administered to the patient as they subjectively
felt the effect of the ﬁrst dose of levodopa was wearing off, even
though no signiﬁcant deterioration of the UPDRS III score was noticed.
We then waited 30min before resuming the experiment.
A baseline recording without stimulation was performed ﬁrst and
then STN stimulated at 5, 10, 15, 20 and 30Hz in London, and
5 and 20Hz in Marseille. Stimulation frequencies were assessed in
pseudo-randomized order across patients and patients were not
informed of the stimulation frequency. The stimulation settings
(i.e. contacts and parameters) used during the experiments are sum-
marized in Supplementary Table 1. In order to diminish the duration of
the experiments, we waited 5min after changing between frequencies
before recording since it has been previously shown that this
short duration is sufﬁcient to produce a practical steady state in
Parkinsonian motor symptoms (Moro et al., 2002).
EEG recordings
Patients were comfortably seated in a chair during the whole experi-
ment. In London, scalp EEG was recorded through 19 Ag/AgCl
electrodes covering the scalp according to the 10:20 international
system and referenced to linked ear electrodes. One additional
electrode was used to record the stimulus artefact and was located
either along the wire ipsilateral to the stimulated STN (close to the
burr-hole or to the mastoid) or in the vicinity of the stimulator case,
whichever produced the highest amplitude artefact. Signals were
ampliﬁed and ﬁltered (band-pass ﬁlter: 0.25–300Hz) and sampled
at 1500Hz using a Brain Dynamics Analyzer ampliﬁcation system
(St Petersburg, Russia) and custom-written software (developed by
A.P.). In addition, the signal from the electrode recording the stimulus
artefact was ampliﬁed and ﬁltered (band-pass ﬁlter: 530–30000Hz)
using a Digitimer160 ampliﬁer (Digitimer Ltd, Hertfordshire, UK) and
processed through an amplitude discriminator (custom-made Schmitt
trigger) that produced a timing pulse coincident with the peak of
the artefact, so that both analogue and digital representations of the
stimulus timing (artefact) were recorded. In Marseille, scalp EEG was
recorded using 11 Ag/AgCl electrodes covering the sensorimotor
cortex (Fp1, Fp2, F3, F4, Fz, C3, C4, Cz, P3, P4, Pz) referenced to
linked ear electrodes. Signals were ampliﬁed and ﬁltered (band-
pass ﬁlter: 0.25–300Hz) and sampled at 2048Hz using a Porti
ampliﬁcation system (TMS International, Oldenzaal, The Netherlands)
and custom-written software (developed by A.P.). All recordings were
performed at rest during 120s after waiting 5min between each
frequency change.
Signal analysis
Recordings were edited using custom-made software (EditEEG,
developed by A.P.). Sections with artefacts from eye movements or
scalp muscle activation were deleted. Recordings were then imported
into Spike version 2.06 (Cambridge Electronic Design, Cambridge,
UK) using a custom-made script. The mean durations of the recordings
in the OFF and ON conditions were 114.4s 2.2 and 103.7s 2.4 for
5Hz, 115.0s 2.3 and 99.6s 3.2 for 10Hz, 114.4s 2.2 and
104.0s 3.2 for 15Hz, 113.8s 3.0 and 107.2s 3.4 for 20Hz,
115.2s 2.6 and 99.8s 4.4 for 30Hz for the patients from
London (Group 1), and 80.4s 3.6 and 86.0s 8.1 for 5Hz and
82.6s 6.8 and 75.6s 4.4 for 20Hz for the patients from
Marseille (Group 2). For each recording, channels were averaged
around each artefact (trial width 0.4s; offset 0.2s) using Spike
version 2.06. The mean number of sweeps averaged in the OFF and
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977 32 for 10Hz, 1697 41 and 1553 43 for 15Hz, 2275 60
and 2144 69 for 20Hz, 3428 87 and 2993 131 for 30Hz for
the patients from London (Group 1) and 402 18 and 430 41 for
5Hz and 1652 135 and 1512 88 for 20Hz for the patients from
Marseille (Group 2). The recording lengths were slightly shorter in the
ON-state compared with the OFF-state in the London group due
to the presence of muscular artefacts caused by levodopa-induced
dyskinesias, resulting in the deletion of larger sections of the record-
ings. Analysis of the averaged trials in the OFF-drug state showed that
DBS consistently induced a signiﬁcant cEP at 5Hz with a peak latency
of 18–25ms in all but one patient (Case No. 8 in Supplementary
Table 1), who was excluded from further analysis. The peak was con-
sidered signiﬁcant when its amplitude exceeded 2 SD of the amplitude
of the baseline trace (95% conﬁdence limit) in at least one electrode
over the sensorimotor cortex. The baseline trace was obtained by
averaging the EEG recording in the OFF-drug state around ﬁctitious
events created in Spike at 5Hz when the stimulator was turned off
(mean number of sweeps: 564 13, not signiﬁcantly different from
the number of sweeps during genuine 5Hz stimulation). The SD was
measured for the 200ms between each ﬁctitious event. Short (3–8ms)
latency cEPs were not consistently seen, at least partly because of
stimulation artefact. Cortical maps of the cEP amplitude averaged
between 15 and 30ms for all electrodes were created in Matlab
version 7.0.1 (The Mathworks Inc., Lowell, MA, USA) for the
London patients and revealed maximum amplitudes over the sensori-
motor, premotor and mesial cortices (Fig. 1). This was conﬁrmed in an
ANOVA of the cEP amplitude averaged between 15 and 30ms for the
ipsilateral, contralateral and mesial pairs of electrodes across the
ﬁve different frequencies in both drug-states (3 levels 5
levels 2 levels). We found a signiﬁcant effect of the pair of electro-
des [F(2,12)=10.493, P=0.002] and within-subject contrasts revealed
that the amplitude of the evoked potential was signiﬁcantly higher
for both mesial and ipsilateral electrodes compared with the con-
tralateral electrodes across frequencies [F(1,6)=30.798, P=0.001
and F(1,6)=11.011, P=0.016, respectively; see Supplementary
Fig. 1]. We thus analysed the cEPs in the corresponding electrodes
(e.g. F3/F4, C3/C4, Fz, Cz) and decided accordingly to reduce the
number of EEG electrodes in the Marseille patients. The peak latency
of the ﬁrst consistent cEP wave was measured for each patient
(one side per patient) and at each stimulation frequency as the peak
latency of the cEP averaged across these six electrodes between
15 and 30ms. The cEPs were then averaged for each patient across
the four electrodes covering the ipsilateral and mesial sensorimotor
cortex obtained at different stimulation frequencies for further
analyses. Similar cEPs were obtained with a ﬁxed number of sweeps
across stimulation frequencies instead of a ﬁxed recording length (see
Supplementary Fig. 2 and supplementary Table 2). We did not attempt
a thorough source localization due to the relatively small number of
electrodes used and the presence of burr holes.
Oscillation modelling
A free natural oscillation is damped if there is an external damping
force to resist its changing and this was the model we choose to
Figure 1 Shape and distribution of the cortical evoked potentials. (A) Example of cEP in Case 1 from Group 1 (see Supplementary
Table 1) OFF-drug during 5Hz stimulation. The time period over which cEP amplitude was averaged in B and C is indicated by the grey
box. The initial portion of the trace (up to  5ms) is dominated by stimulation artefact. (B and C) Scalp maps of peak amplitudes of
cEPs of 15–30ms latency averaged across all seven patients in OFF-drug (B) and ON-drug (C) states for each stimulation frequency.
Where necessary data were ﬂipped so that scalp maps correspond to right hemisphere stimulation.
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oscillation can be described by a two-order differential equation as
m€ x þ c_ x þ kx ¼ 0 ð1Þ
where x(t) is the damped oscillation, _ x and € x are ﬁrst- and second-
order differentiation of x(t). Parameters m and k are the mass and
elasticity constant. Parameter c is a damping constant, which is related
to the level of damping force. Damping force is directly proportional
to the changing of oscillation x(t)a sF ¼  c_ x. If we deﬁne
!n ¼
ﬃﬃﬃﬃ
k
m
r
,   ¼
c
2
ﬃﬃﬃﬃﬃﬃﬃ
km
p
where !n is the natural frequency in radians of the undamped natural
oscillation.   is a damping factor.
Then the damped oscillation x(t) is expressed in the following
function as the solution of Equation (1)
xt ðÞ¼X0e  !nt cos
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1    2!nt    0
p   
ð2Þ
 0 is the initial phase angle of the oscillation. X0 is the amplitude of the
natural oscillation.
When   is zero, the oscillation is a free natural oscillation without
damping. When   is 1, the oscillation is critically damped and the
solution of the Equation (1) becomes
xt ðÞ¼ X0 þ _ x 0 ðÞ þ !nX0 ðÞ t ðÞ e !nt ð3Þ
where _ xð0Þ is a constant of the initial value of _ x.
As the recorded physiological signal usually has a ﬂoating baseline,
we adjusted Equations (2) and (3) as
xt ðÞ¼X0e  !nt cos
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1    2!nt    0
p   
þ At þ D ð4Þ
xt ðÞ¼ X0 þ _ x 0 ðÞ þ !nX0 ðÞ t ðÞ e !ntþAt þ D ð5Þ
where At+D represents the linear or constant ﬂoating baseline.
The parameters X0, !n,   and  0 were estimated from the average
evoked cortical potentials at 5, 10, 15, 20 and 30Hz stimulation
in Matlab version 7.0.1 (The Mathworks Inc., Lowell, MA, USA).
The stimulation artefacts were deleted from the ERP, to avoid the
inﬂuences of artefacts on parameter estimation (See Supplementary
Fig. 3). The processed ERP was then ﬁtted with the waveform gener-
ated by Equation (3) according to the least mean square principle. The
optimized parameters were iteratively computed till the mean square
of the residual between the average ERP and ﬁtting waveforms was
minimal.
We only analysed data between stimulus artefacts over a single
averaged stimulation cycle. This meant that stimulation artefact
was not analysed but fewer data points were analysed for higher
stimulation frequencies. However, qualitatively similar results were
derived when several stimulation cycles of stimulation at 15–30Hz
were considered with the artefact deleted, so that similar numbers
of data points were analysed across frequencies (data not shown).
We ﬁrst ﬁtted the traces averaged across subjects for each stimulation
frequency and both OFF- and ON-drug states. Wavelet transform
ﬁlters were used to clean the average ERP as they provided reliable
decomposition according to the waveform of short data segment.
The data were low-pass ﬁltered to remove EMG activity (London:
80–90Hz for all stimulation frequencies, except for 30Hz where a
low pass of 135Hz was used; Marseille: 110–120Hz for both
5 and 20Hz). In addition, a linear ﬂoating baseline for 5Hz (constant
baseline for all other frequencies) was incorporated in the model so as
to correct for DC offsets.
Both cEPs averaged across groups (London and Marseille) and
within patients were ﬁtted using the above procedures. When analys-
ing data from individual patients, the last 60ms of the 200ms cEP
trace was deleted from one case from London and the last 90ms was
deleted in three cases from Marseille due to muscular artefacts.
One case from London showed a natural frequency of 48Hz, with a
 20Hz component being identiﬁed in the residual to this ﬁt. It was
the results from the latter ﬁt that were considered further as this
lower frequency component appeared homologous to that seen in
the remaining individual subjects in whom the predominant natural
frequency was around 20Hz. Note that harmonically related com-
ponents may not merely reﬂect irregularities in waveform shape but
can also be accompanied by multi-unit activity in resonant brain
systems (Rager and Singer, 1998).
Finally, we simulated the response of an oscillating system with
a natural frequency of 20Hz and variable damping factors
(0.05–0.6) when the system was driven by impulse input at frequen-
cies from 1 to 60Hz. The initial undamped amplitude was set as one
and the peak amplitude relative to the initial value was extracted
from the model for various stimulation frequencies and damping
factors (Fig. 3).
Transfer function
The transfer function was estimated by ﬁtting a convolution kernel
which best predicted the EEG signal using the stimulus train.
Speciﬁcally, we ﬁt the following model:
yt ðÞ¼a þ
X n
k¼0
hk ðÞ st  k ðÞ þ   ð6Þ
where y(t) is the EEG signal, h(k) is the convolution kernel, and s(t k)
is the stimulus train and   is a Gaussian random variable. The con-
volution kernel was then estimated by minimizing the sum of the
squared error (SSE) of the estimate of y
SSE ¼ yt ðÞ  a þ
X n
k¼o
hk ðÞ st  k ðÞ
 !  ! 2
ð7Þ
using linear regression techniques. The frequency domain repre-
sentation was then found by taking the Fourier transform of the
convolution kernel, h(k), with respect to k.
The transfer function, unlike the oscillation model, which operates
on the average stimulus triggered cEP, controls for the fact that some
stimuli arrive before the effects of the previous stimuli have gone to
zero. More speciﬁcally, the transfer function controls for autocorrela-
tion in the input stimulus. This is because the transfer function esti-
mate, h, is equal to the cEP premultiplied by the inverse of the
autocorrelation matrix of the stimulus. To see this, if we put the raw
cEP data into a vector, y and the lagged stimulus values into a matrix
S, we can write the solution of the vector of the convolution kernel as
h ¼ STS
    1
STy: ð8Þ
These are the normal equations from regression, i.e. they are the
equations used to ﬁnd the solution to the coefﬁcients in multivariate
regression (Draper and Smith, 1998). The matrix S
TS is equivalent to
the autocorrelation matrix of the stimulus train, and the vector S
Ty is
equivalent to the average evoked potential. Thus, pre-multiplying by
the inverse of S
TS deconvolves the transfer function estimate. If the
input stimulus were truly a delta function, or if it were white noise, this
step would not be necessary. If the stimulus were white noise,
the matrix S
TS is a scaled identity matrix, and therefore it would
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Statistics
cEP amplitudes, latencies, ﬁtted oscillator parameters (undamped
amplitude, damping coefﬁcient and natural frequency) and transfer
function derived amplitudes were normally distributed (One-sample
Kolmogorov Smirnov tests P40.05). Repeated measures ANOVAs
with repeated within-subjects contrasts were performed to compare
the effects of drug-state and different frequencies of stimulation on
cEP latencies and predominant cortical distribution. Mauchly’s test was
used to determine the sphericity of the data entered in the ANOVAs,
and where data were non-spherical Greenhouse-Geisser corrections
applied. Oscillator parameters were compared using two-tailed,
paired Student’s t-test (using step-wise correction for multiple compar-
isons). Means  SEM are presented throughout the text. All statistical
analyses were performed in SPSS (SPSS for Windows version 12, SSPS
Inc., Chicago, Illinois, USA).
Results
We stimulated the STN with trains of delta functions (pulses)
at lower frequencies than used clinically in two groups of
eight Parkinson’s disease patients from different surgical centres,
and contrasted the amplitudes of the potentials evoked in cortex
(cEPs). We stimulated the STN only on the most severely affected
side demonstrating the best clinical beneﬁt to therapeutic
stimulation.
Patient Group 1 (from London)
The natural frequency of the modelled STN-cortical
circuit is about 20Hz
A signiﬁcant cEP (Fig. 1A) was observed in seven patients from
this group during STN stimulation at 5Hz. The peak latency of the
ﬁrst consistent wave of the cortical response was 21.2 1.3ms.
Scalp mapping of the  21ms component during 5Hz stimulation
indicated that cEP amplitude was maximal ipsilateral to the
stimulated STN and over mesial cortical areas (see box in Fig. 1
where hemispheres have been reversed for right-sided stimulation
prior to averaging, and Supplementary Fig. 1). Accordingly, we
focused on the cEPs recorded through the four electrodes covering
the ipsilateral and mesial sensorimotor cortex, averaging the cEPs
at these sites in each patient. Averaged cEPs to STN stimulation at
5Hz consisted of a series of diminishing waves with periods of
around 50ms (see box in Fig. 2A), consistent with the response
of an impulse forced damped oscillator with a natural frequency of
about 20Hz. To test this, we ﬁtted a damped oscillator function
to the grand average of STN stimulation at 5Hz according to
the least mean squares principle. The ﬁt was excellent (r=0.9,
P50.00001, box in Fig. 2A). The natural frequency of the
damped oscillator ﬁtting the cEP was 19.8 0.1Hz, the undamped
amplitude (e.g. the theoretical amplitude of the response of
the undamped system) 1.7 0.1mV and the damping factor
0.14 0.01.
Oscillatory responses are damped by dopaminergic
therapy
We then recorded cEPs to 5Hz STN stimulation in the same
patients from Group 1 after treatment with levodopa was recom-
menced (hereafter referred to as ON-drug state). This drug helps
restore dopaminergic tone in Parkinson’s disease, and, as is usually
the case, the motor state of our patients improved in the ON-drug
state (see Materials and methods section). The pattern of the cEP
was similar to that OFF-drug, with the exception that successive
waves reduced in amplitude faster in the ON-drug state. The
ON-drug state grand average cEP was again well ﬁtted by a
damped oscillator function (r=0.9, P50.00001, box in Fig. 2A).
The undamped amplitude was the same (1.7 0.1mV) and
the natural frequency of the damped oscillator ﬁtting the cEP
slightly lower (18.1 0.1Hz) than that in the OFF-drug state.
Importantly, however, and consistent with the observation that
successive cEP waves reduced in amplitude faster after levodopa,
the damping factor was  30% higher in the ON-drug state
(0.18 0.01, P=0.001).
The above ﬁndings were corroborated in individual subjects
(Fig. 2C). A damped oscillator function was ﬁtted to the average
cEPs to STN stimulation at 5Hz OFF- and ON-drug from each
subject. Fits in all cases were good (mean r=0.78 0.03, range
0.51–0.95, P50.00001). As above, the undamped amplitude did
not differ between drug-states (2.1 0.7 and 2.2 0.8mVO N
and OFF-drugs, respectively; P=0.733), and the natural frequency
of the damped oscillator ﬁtting the cEP was slightly lower
ON- than OFF-drugs (20.7 4.9 and 22.9 4.4Hz, respectively;
P=0.048). The damping factor was 64% higher ON-drugs
(0.18 0.05) than OFF-drugs (0.11 0.04; P=0.001).
Stimulation at 20Hz provokes resonance and this
resonant response is attenuated by dopaminergic
therapy
The ﬁnding that the natural frequency of the modelled system
underlying the cEP was  20Hz encouraged us to seek evidence
of resonance when this system was forced by stimulating the STN
at 20Hz. To this end, we stimulated STN at several additional
frequencies in the patients from London (10, 15, 20 and 30Hz),
having ﬁrst conﬁrmed that the output current and waveform of
the chronically implanted pattern generator used to stimulate
patients remained constant across the different stimulation frequen-
cies (See Supplementary Fig. 4). As before, we ﬁtted damped oscil-
lator functions to each grand average from stimulation at a given
frequency for each drug state. Fits were very good (r40.94,
P40.00001, Fig. 2A), conﬁrming that the potentials evoked in
cortex by STN stimulation were well described as the response of
an impulse forced damped oscillator at all the frequencies of STN
stimulation tested. Critically, the undamped amplitude of cEPs was
clearly greatest during stimulation at 20Hz (3.1 0.7mVa t2 0 H z
OFF versus 1.7 0.1mV at 5Hz OFF, P=0.0053 corrected for
multiple comparisons; Fig. 2B). There was no difference in
the undamped amplitudes between drug states during 20Hz
stimulation (3.1 0.7mV, both ON- and OFF-drug).
Simulation of the response of an oscillating system with a
natural frequency of 20Hz suggested that the changes in damping
2144 | Brain 2009: 132; 2139–2150 A. Eusebio et al.factors identiﬁed between drug states in patients were sufﬁcient to
make a major difference to resonance phenomena (Fig. 3).
Another relevant factor in this regard was the slight drop in nat-
ural frequency of the damped oscillator ﬁtting the cEP with drug
treatment noted above. This too would contribute to the reduction
in observed resonance during driving at 20Hz, although under
natural conditions pure driving at 20Hz is rather unlikely, as
suggested by the breadth of activity in the beta frequency band
in power spectra of STN local ﬁeld potentials (Brown and Williams,
2005; Bronte-Stewart et al., 2008), so the effect of the drop in
natural frequency upon resonance phenomena may not be as
important as the increase in damping upon treatment. Note that
the response to STN stimulation at 30Hz did not merely recover
after the resonance at 20Hz, but was actually diminished relative
Figure 2 Fittings and parameters of the oscillator OFF- and ON-drugs. (A) Fitting of cEP traces averaged across seven patients in
Group 1 in OFF- and ON-drug states for each stimulation frequency by the function for an impulse forced damped oscillator. Both
the raw (black) and ﬁltered (green) traces are indicated along with the ﬁtted function (pink) (r=correlation coefﬁcient for each ﬁt).
Stimulation artefacts at 55ms latency are deleted for clarity. (B) Undamped amplitude in both drug states (P-values corrected for
multiple comparisons: *P50.05; **P50.005; ***P50.0001) (C) Example ﬁts in two Parkinson’s disease patients (Cases 2 and 3)
stimulated at 5Hz.
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and B). This suggested an additional low-pass ﬁltering effect of
the system underlying the cEP although proof of this would
require stimulation at even higher frequencies.
In the above analysis, we assumed in our modelling that the
responses of the impulse forced oscillator were unaffected by
linear summation of the early evoked components to one pulse
with the later evoked components of earlier pulses. This was not a
factor when modelling the response to 5Hz as Fig. 2A shows that
the response had died off before the next stimulus. However, this
may have been a factor with stimulation at 20Hz, particularly in
the OFF-drug state where the damping of successive oscillations
was reduced. To investigate this point further we used an
alternative approach involving the transfer function that modelled
the effect of the most recent stimulus having allowed for the
effect of earlier stimuli on the evoked activity in each subject.
An ANOVA of FREQUENCY (5 levels: 5, 10, 15, 20 and 30Hz)
in the OFF-drug state conﬁrmed an effect of frequency
[F(4,24)=4.681, P=0.006] and within-subjects contrasts indicated
that the response to 20Hz stimulation was greater than that to
5Hz stimulation [F(1,6)=7.308, P=0.035]. Thus, irrespective
of any effect of linear summation, the response to an input
at 20Hz was bigger than that to an input at 5Hz (See
Supplementary Fig. 5).
The properties of the network change with dopamine
and stimulation frequency but the network itself
remains the same
Our core results suggested that basal ganglia cortical circuits may
have a natural oscillation frequency of about 20Hz, that the
amplitude of the cortical response to STN stimulation increases
when the system is driven at or near its natural frequency and
that this resonance phenomenon is predominantly limited by
damping which is under the strong inﬂuence of dopaminergic
input. This physiological interpretation assumes that the cortical
response to STN stimulation at different frequencies and in differ-
ent drug states has essentially the same mechanism. This assump-
tion is supported by three observations. First, the same damped
oscillator model ﬁtted the grand average data well across stimu-
lation conditions. Second, the latency of the initial wave in the cEP
remained similar across conditions. Thus there was no signiﬁcant
effect of stimulation frequency, drug-state nor interaction
between these two factors on the latencies of this wave as
revealed by an ANOVA of latencies with factors FREQUENCY
(5 levels: 5, 10, 15, 20 and 30Hz) and STATE (two levels:
OFF-drug and ON-drug). Third, the relative scalp topography
(but not amplitude; Fig. 1B and C) of the cEP remained similar
across conditions.
Patient Group 2 (from Marseille)
A natural frequency of about 20Hz and increased
damping with dopamine are consistent features
In order to determine the reproducibility of our core ﬁndings in
patient Group 1 we repeated the experiment in an independent
population of eight Parkinson’s disease patients (Group 2) from a
different surgical centre (Marseille). The cEPs were recorded
during 5Hz STN stimulation both in OFF- and ON-drug states.
As before, the cEPs averaged over the ipsilateral and mesial
sensorimotor cortex, consisted of a series of diminishing waves
with a peak latency of 21.6 0.6ms for the ﬁrst consistent
wave. The ﬁtted grand average cEP (r=0.9 OFF and 0.95 ON,
P50.00001, for both) had a natural frequency of 21.8 0.1Hz
OFF and 20.8 0.1Hz ON (P50.00001) and a damping factor
of 0.13 0.01 OFF drugs increasing by 85% to 0.24 0.01
ON-drugs (P50.00001; Fig. 4). As before the undamped ampli-
tude of cEPs was greater during stimulation at 20Hz (3.9 0.3mV
at 20Hz) than during 5Hz stimulation OFF (P=0.002; Fig. 4).
The only major difference between this cohort of Parkinson’s
disease patients and those reported above was a higher
undamped amplitude OFF (2.8 0.1mV; P50.00001 OFF Group
1 versus Group 2) that increased even further ON-drugs during
5Hz stimulation (4.4 0.2mV; P50.00001 Group 2 OFF
versus ON).
The above ﬁndings were corroborated in individual subjects. A
damped oscillator function was ﬁtted to the average cEPs to STN
stimulation at 5Hz OFF- and ON-drug from each subject. Fits
in all cases were good (mean r=0.85 0.03, range 0.66–0.95,
P50.00001). As above, the damping factor signiﬁcantly increased
by 53% ON-drugs (0.26 0.04) compared with OFF-drugs
(0.17 0.04; P50.05). The modelled natural frequency
(20.2 1.2 and 22.0 1.1 ON- and OFF-drugs, respectively;
P=0.19) nor the modelled undamped amplitude (4.8 0.7mV
and 3.5 0.6mV ON- and OFF-drugs, respectively; P=0.16)
were signiﬁcantly different between drug-states. In summary,
the natural frequency of about 20Hz and the increased damping
Figure 3 Simulation of response of an oscillating system
with a natural frequency of 20Hz showing dependency of
resonance phenomena on damping factor. Changes in
damping factor of the same degree as seen with the shift from
the OFF- to ON-drug state, are sufﬁcient to have a major
effect on the amplitude of oscillations during stimulation at
20Hz. Note there is a dip in amplitude with stimulation at
15Hz that parallels the dip in undamped amplitude in Fig. 2B.
White horizontal lines indicate a damping factor of 0.18 (ON)
and 0.14 (OFF), as in patient Group 1, and vertical lines
indicate 5 and 20Hz stimulation.
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tent ﬁndings within and across the two patient groups.
Discussion
Our ﬁndings are compatible with a scheme in which, at the
systems level, basal ganglia cortical circuits can act as an oscilla-
tor, with a tendency to resonate at around 20Hz. Ordinarily,
dopaminergic input to the basal ganglia cortical system effectively
increases the damping of oscillations, thereby limiting resonance
phenomena in these circuits. However, in the relative absence of
dopaminergic input in the untreated Parkinson’s disease patient
the system becomes less damped and thus, resonance is more
marked, contributing to the relatively preferential propagation
and ampliﬁcation of activities synchronized around 20Hz. Our
study focused on the dynamic response of basal ganglia–cortical
circuits over ﬁve to 30Hz, in line with the evidence for exagger-
ated and distributed oscillation at similar frequencies in the
basal ganglia–cortical system of patients with Parkinson’s Disease
demonstrated by multiple groups (Brown et al., 2001; Cassidy
et al., 2002; Williams et al., 2002; Priori et al., 2004; Alegre
et al., 2005; Foffani et al., 2005; Kuhn et al., 2005; Alonso-
Frech et al., 2006; Devos et al., 2006; Fogelson et al., 2006;
Weinberger et al., 2006; Lalo et al., 2008; Steigerwald et al.,
2008; Bronte-Stewart et al., 2009). However, as such we cannot
exclude additional resonances at other frequencies, such as that
reported in the cerebral cortex at frequencies around or above
100Hz during DBS (Li et al., 2007; Montgomery and Gale, 2008).
The above interpretation of our ﬁndings makes no assumption
regarding the site or sites within the circuit responsible for the
oscillatory response. Although evident in the cEP, the resonance
at  20Hz could have been partially or entirely generated at a
subcortical relay and activity then propagated to the cortex.
However, independent estimates of the preferred frequency
response of circuits involving frontal and sensorimotor cortical
areas generally also implicate frequencies of about 20Hz. Thus,
the natural frequency of the damped oscillator ﬁtting the
evoked responses corresponds closely to the frequency of steady
state sensorimotor cortical responses to peripheral vibration
(Tobimatsu et al., 1999), the predominant frequency of cortico-
muscular coherence (Gilbertson et al., 2005) and the predilection
of cortical myoclonus to occur at around 20Hz (Ugawa et al.,
2003).
A related issue is the nature of the pathway activated by STN
stimulation that eventually modulates cortical activity. Previous
reports suggest that the initial cEP wave peaking at  21ms is
the product of activity in the subthalamo–pallidal–thalamo–cortical
pathway (MacKinnon et al., 2005; Tisch et al., 2008), in line with
recent animal work suggesting that regular trains of inhibitory
pallidal discharges can drive phase-locked thalamocortical output,
and hence produce a cEP (Person and Perkel, 2005). Furthermore,
there is no evidence to indicate that later evoked waves
might have a different origin in a system that is known to be
Figure 4 Fittings and parameters of the oscillator OFF- and ON-drugs in an independent Parkinson’s disease patient group. Fitting
of cEP traces averaged across eight patients in Group 2 in OFF- and ON-drug states for 5 and 20Hz stimulation by the function for
an impulse forced damped oscillator. Both the raw (black) and ﬁltered (green) traces are indicated along with the ﬁtted function
(pink) (r=correlation coefﬁcient for each ﬁt). Stimulation artefacts at  5ms latency are deleted for clarity.
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Rivlin-Etzion et al., 2006). Recent data, however, suggest the exis-
tence of direct subthalamo–cortical projections (Degos et al.,
2008) and a fast orthodromic transmission followed by recruit-
ment of cortico-cortical or cortico–subcortico–cortical loops
cannot be excluded. Similarly, anti-dromic stimulation of the
cortex via the hyperdirect pathway is possible, although this is
generally believed to lead to initial activation of the cortex at
latencies of under 10ms (Ashby et al., 2001; Baker et al et al.,
2002; MacKinnon et al., 2005), rather than 21ms as in our
recordings.
On the other hand, the nature of the pathway or pathways
involved in the generation of the cEP oscillation does not neces-
sarily impact on the functional signiﬁcance of our ﬁndings as,
irrespective of the pathways involved, the net effect at the cortical
level is the preferential propagation of activities at around 20Hz in
untreated Parkinson’s disease. The precise mechanisms by which
restoration of dopaminergic input can modify the damping of
oscillations and attenuate expression of 20Hz activity at the
cortical level remain unclear. One possibility is that dopamine
alters voltage-dependent conductances (Nicola et al., 2000)
that may act to dampen oscillations (Gutfreund et al., 1995).
Alternatively, dopamine may alter potential re-entrant mechanisms
in the basal ganglia–thalamo–cortical loop (Montgomery and
Gale, 2008).
It is interesting to note that the natural frequency of around
20Hz identiﬁed here is paralleled by the pattern of STN-cortical
coherence in previous studies (Williams et al., 2002; Fogelson
et al., 2006; Lalo et al., 2008). This suggests that the network
properties characterized here may be of functional relevance in
the ampliﬁcation and propagation of spontaneous pathological
oscillations in Parkinson’s disease patients. However, further stu-
dies are required in peri-operative patients to determine whether
the modelled natural frequency in each subject corresponds to the
peak frequency of their STN-cortical coherence. The latter would
be preferable to comparison with the peak frequency of their
motor cortical EEG activity in the beta band, which may reﬂect
synchronization supported not only by the basal ganglia, but also
by cortico–cortical interactions and cerebello–thalamo–cortical
relays (Marsden et al., 2000).
Another feature of note was that the response to STN stimula-
tion at 30Hz did not merely recover after the resonance at 20Hz,
but was actually diminished relative to stimulation at 5Hz, regard-
less of drug state. This might reﬂect low-pass ﬁltering by the skull
and scalp and/or an additional low-pass ﬁltering effect of
the system underlying the cEP, consistent with a polysynaptic
subthalamo–pallidal–thalamo–cortical relay, as frequency following
in polysynaptic circuits tends to fail at higher frequencies. This
might help explain why coherence between basal ganglia sites
and cortex at frequencies in the gamma band is unusual, even
though local ﬁeld potentials power in the STN often has a discrete
gamma band peak in treated patients (Marsden et al., 2001;
Williams et al., 2002; Alegre et al., 2005; Fogelson et al.,
2005b; Alonso-Frech et al., 2006; Devos et al., 2006), contrasting
with the stereotypical coherence between basal ganglia sites and
cortex in the beta band in patients with Parkinson’s disease
(Marsden et al., 2001; Williams et al., 2002; Fogelson et al.,
2006; Kuhn et al., 2006a).
Finally, it is interesting to note that the natural frequency
of around 20Hz measured in our patients corresponds to the
frequency band associated with slowness of movement in both
correlative (Brown and Williams, 2005; Kuhn et al., 2006b,
2008, 2009; Weinberger et al., 2006; Ray et al., 2008) and inter-
ventional (Fogelson et al., 2005a; Chen et al., 2007; Eusebio
et al., 2008) studies of STN. In the latter case there is evidence
for impairment in motor function during stimulation of STN at
around 20Hz, but not at 15 or 30Hz, when stimulation is
performed in Parkinson’s disease patients withdrawn from medi-
cation (Fogelson et al., 2005; Chen et al., 2007; Eusebio et al.,
2008). This parallels the pattern of modelled resonance shown
here. Indeed, stimulation at 40 and at 60Hz is believed to improve
some aspects of parkinsonism (Moreau et al., 2008; Brozova
et al., 2009), as well as of dystonia and chorea (Moro et al.,
2004; Alterman et al., 2007; Guehl et al., 2007). Likewise, our
study provided evidence of a smaller tendency to resonance in the
evoked response to stimulation of the STN at 10Hz, evident
in both the scalp topography of the cortical response at about
20ms and in our simulations. It may be relevant, therefore, that
exacerbations of motor impairment may also be seen with 10Hz
stimulation of the STN (Timmermann et al., 2004), although the
same group has highlighted that this effect may be reversed when
some cognitive functions are considered (Wojtecki et al., 2006),
and the above observations may not apply to all targets for DBS
in movement disorders. Thus stimulation of the region of the
pedunculopontine nucleus at about 20Hz is therapeutic (Lim
et al., 2007; Stefani et al., 2007). Taken together these observa-
tions suggest that there may be several basal ganglia–cortical net-
works subserving different aspects of impairment in Parkinson’s
disease and each with its own pattern of susceptibility to reso-
nance phenomena (Fogelson et al., 2006). Of these, the motor
circuit involving STN may be particularly susceptible to frequencies
of around 20Hz, at least when dopaminergic activity is low.
In summary, the data presented here help explain why excessive
neuronal synchrony at around 20Hz in patients with Parkinson’s
disease is so remarkably propagated around the basal ganglia–
cortical circuit involving the STN, leading to coherent activity
over multiple levels within this circuit. The results show that this
basal ganglia–cortical network has a tendency to resonate at
 20Hz, thereby both propagating and amplifying spontaneous
pathological activities at this frequency. Critically, dopamine acts
to increase damping and thereby limit resonance in this basal
ganglia–cortical network.
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Supplementary material is available at Brain online.
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